mRNA |
BRD-K92856060 |
CTRPv2 |
pan-cancer |
AAC |
0.084 |
0.03 |
mRNA |
BRD-K51831558 |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
0.03 |
mRNA |
BRD-K52037352 |
CTRPv2 |
pan-cancer |
AAC |
0.093 |
0.03 |
mRNA |
barasertib |
CTRPv2 |
pan-cancer |
AAC |
0.073 |
0.03 |
mRNA |
crizotinib:PLX-4032 (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.078 |
0.03 |
mRNA |
YM-155 |
CTRPv2 |
pan-cancer |
AAC |
0.085 |
0.03 |
mRNA |
BRD-K66532283 |
CTRPv2 |
pan-cancer |
AAC |
-0.075 |
0.03 |
mRNA |
tanespimycin:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.085 |
0.03 |
mRNA |
AZD8055 |
CTRPv2 |
pan-cancer |
AAC |
-0.078 |
0.04 |
mRNA |
BRD-K41597374 |
CTRPv2 |
pan-cancer |
AAC |
0.077 |
0.04 |